Michel Dorval is a Full Professor at the Laval University Faculty of Pharmacy, and scientist at the Centre de recherche du CHU de Québec-Axe Oncologie. He holds a master’s degree in Psychology (1984) and a Doctorate in Epidemiology (1997) from Laval University, complemented by postdoctoral training from the Dana-Farber Cancer Institute (Harvard Medical School) thanks to a Terry Fox Fellowship from the National Cancer Institute of Canada. From 1999 to 2011, he has constantly held research career awards (Junior I, Junior II, Senior) from the Fonds de la recherche du Québec-Santé (FRQS).

Since the mid 90’s, his research has focused on the psychosocial issues related to hereditary and familial breast cancer. From 2001 to 2007, he led the psychosocial component of the research program INHERIT BRCAs (Interdisciplinary Health Research International Team on Breast Cancer Susceptibility), which was then funded in 2008 as a CIHR team working on the familial risks of breast cancer. Using a variety of quantitative and qualitative methodological approaches, his team highlighted the relevance of providing psychosocial support to women tested for a genetic predisposition to breast and ovarian cancers and demonstrated the importance of providing continuing medical education on hereditary cancers to primary care physicians.

In 2012, his work led to the creation of the Centre ROSE (Ressources en Oncogénétique pour le Soutien et l’Éducation), which he co-founded with his colleague Dr. Jocelyne Chiquette thanks to funding from the Quebec Breast Cancer Foundation. The Centre ROSE‘s mission is to inform and support people with an inherited cancer risk, and to provide education on hereditary cancers to healthcare professionals, based on evidence. Since 2015, the Centre ROSE has evolved into the Réseau ROSE (Network) by adding satellites in the Montreal, Saguenay-Lac St-Jean, and Lower Saint-Lawrence regions. Since its creation, the Centre ROSE has received various awards, including Hommage aux Innovations Sociales from Laval University (2014), the Community Innovation Award of Excellence from the Quebec Breast Cancer Foundation (2016), and the Health Promotion and Prevention Award from the Direction générale de cancérologie du Québec (2016).

Hôpital Saint-Sacrement
1050, chemin Sainte-Foy
J0-21
Québec, Québec
Canada G1S 4L8
59 entries « 1 of 6 »

Hébert J, Bergeron AS, Veillette AM, Bouchard K, Nabi H, Dorval M

Issues associated with a hereditary risk of cancer: Knowledge, attitudes and practices of nurses in oncology settings

Journal Article

Can Oncol Nurs J, 32 (2), 2022.

Abstract | Links:

Hébert J, Bergeron AS, Veillette AM, Bouchard K, Nabi H, Dorval M

Enjeux associés au risque héréditaire de cancer: connaissances, attitudes et pratiques infirmières en oncologie

Journal Article

Can Oncol Nurs J, 32 (2), 2022.

| Links:

Ahmed S, Lévesque E, Garland R, Knoppers B, Dorval M, Simard J, Loiselle CG

Women's perceptions of PERSPECTIVE: a breast cancer risk stratification e-platform

Journal Article

Hered Cancer Clin Pract, 20 (1), 2022.

Abstract | Links:

Barrault-Couchouron M, Béracochéa M, Dorval M, Allafort V, Barthélémy V, Garguil V, Auriacombe M, Bussières E, M'bailara K

[Tobacco and alcohol consumption in women treated for breast cancer in a department of surgical oncology: Frequent behaviours to consider]

Journal Article

Bull Cancer, 109 (3), 2022.

Abstract | Links:

Cléophat JE, Dorval M, El Haffaf Z, Chiquette J, Collins S, Malo B, Fradet V, Joly Y, Nabi H

Whether, when, how, and how much? General public's and cancer patients' views about the disclosure of genomic secondary findings

Journal Article

BMC Med Genomics, 14 (1), 2021.

Abstract | Links:

Plante M, Garneau L, Laprise-Lachance M, Lemieux P, Dorval M

Impact of Split Dosing the First Rituximab Infusion in Patients with High Lymphocyte Count

Journal Article

Curr Oncol, 28 (5), 2021.

Abstract | Links:

Villafane-Bernier C, Lapointe J, Raîche C, Lauzier S, Chiquette J, Bouchard K, Pelletier S, Omeranovic A, Rhéaume J, Brousseau C, Hébert J, Dorval M, Nabi H

Cross-Cultural Adaptation and Validation of a French Version of the Genetic Counseling Satisfaction Scale (GCSS) as an Outcome Measure of Genetic Counseling for Hereditary Breast and Ovarian Cancer

Journal Article

Healthcare (Basel), 9 (9), 2021.

Abstract | Links:

Pashayan N, Antoniou AC, Lee A, Wolfson M, Chiquette J, Eloy L, Eisen A, Stockley TL, Nabi H, Brooks JD, Dorval M, Easton DF, Knoppers BM, Chiarelli AM, Simard J

Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening?

Journal Article

J Pers Med, 11 (9), 2021.

Abstract | Links:

Brooks JD, Nabi HH, Andrulis IL, Antoniou AC, Chiquette J, Després P, Devilee P, Dorval M, Droit A, Easton DF, Eisen A, Eloy L, Fienberg S, Goldgar D, Hahnen E, Joly Y, Knoppers BM, Lofters A, Masson JY, Mittmann N, Paquette JS, Pashayan N, Schmutzler R, Stockley T, Tavtigian SV, Walker MJ, Wolfson M, Chiarelli AM, Simard J

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

Journal Article

J Pers Med, 11 (6), 2021.

Abstract | Links:

Alarie S, Hagan J, Dalpé G, Faraji S, Mbuya-Bienge C, Nabi H, Pashayan N, Brooks JD, Dorval M, Chiquette J, Eloy L, Turgeon A, Lambert-Côté L, Paquette JS, Walker MJ, Lapointe J, Granados Moreno P, Blackmore K, Wolfson M, Broeders M, The Perspective I I Study Group , Knoppers BM, Chiarelli AM, Simard J, Joly Y

Risk-Stratified Approach to Breast Cancer Screening in Canada: Women's Knowledge of the Legislative Context and Concerns about Discrimination from Genetic and Other Predictive Health Data

Journal Article

J Pers Med, 11 (8), 2021.

Abstract | Links:

59 entries « 1 of 6 »
Signaler des ajouts ou des modifications

Active projects

  • Comprendre le lien entre le jeu problématique et les troubles psychotiques chez les jeunes : une nouvelle voie vers le rétablissement, from 2020-03-01 to 2023-06-01
  • Exploring the impact for COVID-19 pandemic on women with breast cancer in Quebec, from 2021-12-01 to 2023-09-30
  • FGR - La psilocybine pour soulager la détresse existentielle en fin de vie : Audace, acceptabilité et accès, from 2021-11-12 to 2022-11-11
  • La psilocybine pour soulager la détresse existentielle en fin de vie: Audace, acceptabilité et accès, from 2022-04-01 to 2024-03-31
  • Personalized Risk Assesment for Prevention and Early Detection of Breast Cancer : Integration and Implementation (PERSPECTIVE II), from 2017-11-01 to 2024-03-31
  • What are my options? A feasibility study of a personalized primary prevention strategy for women and men at high risk of breast and prostate cancer, from 2022-01-15 to 2023-01-14

Recently finished projects

  • Conseil génétique concernant le risque héréditaire de cancer du sein: Comment améliorer l’offre de services pour préserver la qualité de vie et la satisfaction des femmes potentiellement à risque?, from 2019-01-01 to 2021-01-31
  • Le patient accompagnateur, une ressource organisationnelle comme levier pour une expérience patient améliorée en oncologie (PAROLE-Onco), from 2017-07-01 to 2021-06-30
  • Pilot study of a community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast, from 2019-10-01 to 2022-02-28
  • Quand innovations technologique et organisationnelle vont de pair: Un modèle collaboratif pour rendre l'oncogénétique plus agile, accessible et efficiente, from 2020-04-01 to 2022-03-31
  • Réseau R.O.S.E., from 2015-08-01 to 2021-07-31
Data provided by the Université Laval research projects registery